Bayer (1BAYN) Stock Price & Analysis
1BAYN Stock Chart & Stats
- Day’s Range
- EUR 49.46 - EUR 50.58
- 52-Week Range
- EUR 25.82 - EUR 53.98
- Previous Close
- EUR 46.32
- Volume
- 12.76K
- Average Volume (3M)
- 19.04K
- Market Cap
- EUR 49.69B
- Enterprise Value
- EUR 81.83B
- Total Cash (Recent Filing)
- EUR 5.08B
- Total Debt (Recent Filing)
- EUR 38.43B
- Price to Earnings (P/E)
- ―
- Beta
- 0.72
- Next Earnings
- Nov 03, 2026 (Est.)
- EPS Estimate
- 0.39
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- 0.22%
Bulls Say, Bears Say
Bulls Say
Diversified Life-Sciences Model
Bayer’s presence in both healthcare and agriculture gives it multiple end markets, product categories, and sources of revenue. This diversification can reduce reliance on one therapeutic area or crop cycle and provides a broader platform for deploying research, brands, and distribution capabilities over time.
Positive Operating Cash Flow
Persistent positive operating and free cash flow indicates that Bayer’s businesses continue to generate cash even while reported earnings are negative. This supports ongoing investment in research and development, debt service, and operations, although the recent decline means cash generation is not yet fully predictable.
Strengthening NUBEQA Evidence
The NUBEQA data expand evidence for Bayer’s oncology franchise in high-risk prostate cancer and show a substantial improvement in metastasis-free outcomes. Strong clinical results can support broader adoption, reinforce the product pipeline, and improve the Pharmaceuticals segment’s longer-term growth potential.
Bears Say
Persistent Net Losses
Sustained net losses and weak operating profitability show that solid gross margins are not translating into dependable earnings. This constrains internally funded growth, reduces resilience against additional operating pressures, and raises uncertainty about when the underlying portfolio will produce consistently attractive returns.
Material Leverage
Historically elevated leverage limits Bayer’s financial flexibility while returns remain negative. A substantial debt burden can absorb cash that might otherwise fund innovation or portfolio development, and it leaves less capacity to respond to setbacks, invest through a downturn, or pursue strategic opportunities.
Weak Revenue And Cash Momentum
The multi-year revenue decline indicates pressure on demand, pricing, product performance, or market conditions across the portfolio. Coupled with a sharp recent free-cash-flow reduction, this weakens confidence in near-term growth funding and makes financial performance more dependent on a future recovery.
1BAYN FAQ
What was Bayer’s price range in the past 12 months?
What is Bayer’s market cap?
When is Bayer’s upcoming earnings report date?
How were Bayer’s earnings last quarter?
Is Bayer overvalued?
Does Bayer pay dividends?
What is Bayer’s EPS estimate?
How many shares outstanding does Bayer have?
What happened to Bayer’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Bayer?
What is the TipRanks Smart Score and how is it calculated?
Bayer Stock Smart Score
Company Description
Bayer
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.
- Sector
- General
- Industry
- Drug Manufacturers - General
- CEO
- Bill Anderson
- Employees
- 87,830
- Website
- www.bayer.com
- Address
- Kaiser-Wilhelm-Allee 1, Leverkusen, NW, 51368, DE
Bayer (1BAYN) Earnings & Revenues
1BAYN Stock 12 Month Forecast
Average Price Target
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 14 | 3 | 5 |
| Technical Analysis | 2 | 3 | 5 |
| Moving Averages | 12 | 0 | 0 |
